Company intelligence / Profile preview

BioCorteX

Ownership: Private
Development stage: Preclinical

Overview

BioCorteX has developed a foundational biology emulator that can test mechanistic links between varied microbiomes and different treatment responses. Their platform has conducted in silico trials of hundreds of medications to understand success factors.

Therapeutic areas: OncologyNeurology
Modalities: Computational biologymicrobiome-based therapeutics
Industry: Drug Discovery Services

Partnerships

Google Cloud

Beyond the preview

Go deeper on BioCorteX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioCorteX.